Please assess the completion status of the following clinical trial:

Trial Title: Low-dose Ketamine vs Morphine for Vaso-occlusive Crisis in Sicklers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children aged 7-18 years~* sickle cell anemia patient with severe acute painful crisis~* Parental consent and child assent where applicable~Exclusion Criteria:~* Oxygen saturations below 90% on initial assessment~* Altered conscious and mental state that hinders communication~* Current enrollment in another clinical trial involving an investigational drug.~* History of a stroke~* Hypertension,~* Increased intracranial pressure.~* Glaucoma,~* Failed/ Difficult IV access

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Low dose ketamine (Type: EXPERIMENTAL): Low dose ketamine 1mg/kg given as an IV infusion via syringe pump over 10 minutes. Maximum of 2 doses to be given during study period that will last 2 hours.
- Morphine (Type: ACTIVE_COMPARATOR): Morphine 0.1mg/kg given as an IV infusion via a syringe pump over 10 minutes. Maximum of 2 doses to be given during the study period that will last 2 hours.

Based on this trial design, predict the completion outcome and termination type (if applicable).